Dragonfly Therapeutics Initiates Phase 1 / 1b Study of its IL-2 Immunotherapy in Patients with Advanced Solid Tumors

Dragonfly Therapeutics, Inc. Massachusetts

View original content:https://www.prnewswire.co.uk/news-releases/dragonfly-therapeutics-initiates-phase-11b-study-of-its-il-2-immunotherapy-in-patients-with-advanced-solid-tumors-302006221.html